Alkermes Inc. plc (ALKS) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 19, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Jul 28, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ALKS SEC filings page.
Alkermes Inc. plc (ALKS) reported $1.7B in revenue over the twelve months to Jun 30, 2026, up 10.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Alkermes turns a smaller revenue base into more cash, while margin compression and higher R&D spending weaken earnings efficiency.
In FY2025, cash conversion outpaced accounting profit: operating cash flow reached$520.8M against net income of$241.7M , lifting free-cash-flow margin to32.6% even as net margin fell to16.4% . This divergence means cash generation was materially stronger than reported earnings, pointing to cash benefits beyond current-period profitability.
Revenue fell from
The balance sheet is increasingly self-funded: debt-to-equity fell from 0.4x in FY2024 to 0.0x in FY2025, while the current ratio rose from 3.0x to 3.5x. That combination gives the cash-producing operation more financial flexibility, even though 2025 net income was below FY2024's level.
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Alkermes Inc. plc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Alkermes Inc. plc has an operating margin of 17.2%, meaning the company retains $17 of operating profit per $100 of revenue. This strong profitability earns a score of 76/100, reflecting efficient cost management and pricing power. This is down from 27.0% the prior year.
Alkermes Inc. plc's revenue declined 5.2% year-over-year, from $1.6B to $1.5B. This contraction results in a growth score of 14/100.
Alkermes Inc. plc carries a low D/E ratio of 0.00, meaning only $0.00 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 97/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 3.55, Alkermes Inc. plc holds $3.55 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 84/100.
Alkermes Inc. plc converts 32.6% of revenue into free cash flow ($480.3M). This strong cash generation earns a score of 93/100.
Alkermes Inc. plc earns a strong 13.3% return on equity (ROE), meaning it generates $13 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 74/100. This is down from 25.1% the prior year.
Alkermes Inc. plc scores 7.66, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($7.2B) relative to total liabilities ($667.7M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Alkermes Inc. plc passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Alkermes Inc. plc generates $2.15 in operating cash flow ($520.8M OCF vs $241.7M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Alkermes Inc. plc earns $20.69 in operating income for every $1 of interest expense ($254.0M vs $12.3M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Alkermes Inc. plc generated $496.0M in revenue in Q2 2026. This represents an increase of 27.0% from the same quarter a year earlier. Against the prior quarter it is up 26.2%.
Alkermes Inc. plc's EBITDA was $48.6M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 51.8% from the same quarter a year earlier. Against the prior quarter it is up 268.6%.
Alkermes Inc. plc reported $501K in net income in Q2 2026. This represents a decrease of 99.4% from the same quarter a year earlier. Against the prior quarter it is up 100.8%.
Alkermes Inc. plc earned $0.00 per diluted share (EPS) in Q2 2026. This represents a decrease of 100.0% from the same quarter a year earlier. Against the prior quarter it is up 100.0%.
Cash & Balance Sheet
Alkermes Inc. plc generated $137.0M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 0.1% from the same quarter a year earlier. Against the prior quarter it is up 180.7%.
Alkermes Inc. plc held $511.5M in cash against $1.5B in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Margins & Returns
Alkermes Inc. plc's gross margin was 80.2% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 7.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.1 percentage points.
Alkermes Inc. plc's operating margin was 3.7% in Q2 2026, reflecting core business profitability. This is down 20.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 16.0 percentage points.
Alkermes Inc. plc's net profit margin was 0.1% in Q2 2026, showing the share of revenue converted to profit. This is down 22.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 17.0 percentage points.
Alkermes Inc. plc's ROE was 0.0% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 5.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.8 percentage points.
Capital Allocation
Alkermes Inc. plc invested $112.9M in research and development in Q2 2026. This represents an increase of 45.9% from the same quarter a year earlier. Against the prior quarter it is up 9.3%.
Alkermes Inc. plc repurchased no shares in Q2 2026. Against the prior quarter it is down 100.0%.
Alkermes Inc. plc invested $8.1M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 37.4% from the same quarter a year earlier. Against the prior quarter it is up 99.2%.
ALKS Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $496.0M+27.0% | $392.9M+28.2% | $384.5M-10.6% | $394.2M+4.2% | $390.7M-2.1% | $306.5M-12.5% | $430.0M+13.9% | $378.1M-0.7% |
| Cost of Revenue | $98.1M+98.4% | $61.6M+25.2% | $46.2M-25.6% | $51.6M-18.2% | $49.5M-19.5% | $49.2M-16.1% | $62.1M-11.4% | $63.1M+2.6% |
| Gross Profit | $397.9M+16.6% | $331.3M+28.8% | $338.3M-8.0% | $342.6M+8.7% | $341.2M+1.0% | $257.3M-11.8% | $367.9M+19.7% | $315.0M-1.4% |
| R&D Expenses | $112.9M+45.9% | $103.3M+43.9% | $93.0M+59.9% | $81.7M+36.5% | $77.4M+29.7% | $71.8M+6.2% | $58.2M-21.3% | $59.9M-7.7% |
| SG&A Expenses | $217.6M+27.4% | $264.6M+54.1% | $187.2M+27.3% | $171.8M+14.2% | $170.8M+1.6% | $171.7M-4.5% | $147.0M-13.4% | $150.4M-3.8% |
| Operating Income | $18.4M-80.3% | -$48.3M-450.1% | $58.1M-64.3% | $89.1M-15.0% | $93.0M-15.4% | $13.8M-68.2% | $162.7M+197.8% | $104.8M+17.4% |
| EBITDA | $48.6M-51.8% | -$28.9M-236.0% | $62.0M-63.5% | $97.2M-13.0% | $100.8M-13.5% | $21.2M-58.7% | $169.5M+131.7% | $111.7M+3.6% |
| Interest Expense | $25.9M | $20.9M | $12.3M+164.1% | $0-100.0% | $0-100.0% | $0-100.0% | $4.6M-23.2% | $6.0M-0.1% |
| Income Tax | -$2.4M-113.4% | $4.6M+50.5% | $11.0M-54.3% | $18.0M+3.1% | $17.7M-19.6% | $3.0M-62.0% | $24.2M+123.6% | $17.4M+1412.1% |
| Net Income | $501K-99.4% | -$66.5M-395.9% | $49.4M-66.3% | $82.8M-10.4% | $87.1M-4.7% | $22.5M-39.0% | $146.5M+29.9% | $92.4M+93.4% |
| EPS (Basic) | $0.00-100.0% | -$0.40-385.7% | $0.30-66.7% | $0.50-12.3% | $0.53-1.9% | $0.14-36.4% | $0.90+32.4% | $0.57+96.6% |
| EPS (Diluted) | $0.00-100.0% | -$0.40-407.7% | $0.29-66.7% | $0.49-10.9% | $0.52-1.9% | $0.13-38.1% | $0.87+27.9% | $0.55+96.4% |
| Diluted Shares (Avg) | 173M+3.0% | 166M-1.5% | N/A | 169M+0.9% | 168M-1.5% | 169M-2.5% | N/A | 167M-2.8% |
ALKS Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.4B+95.0% | $4.3B+104.5% | $2.5B+21.0% | $2.3B+8.1% | $2.3B+2.1% | $2.1B-2.0% | $2.1B-3.8% | $2.2B-5.4% |
| Current Assets | $1.5B-6.9% | $1.4B-8.1% | $1.9B+36.3% | $1.7B+11.3% | $1.6B+6.0% | $1.5B+0.7% | $1.4B-4.7% | $1.6B+6.8% |
| Cash & Equivalents | $511.5M-1.9% | $351.6M-12.1% | $388.6M+33.5% | $616.4M+55.6% | $521.2M-2.6% | $399.8M-5.0% | $291.1M-36.4% | $396.3M-38.8% |
| Short-Term Investments | $145.0M-70.7% | $160.3M-66.9% | $199.6M-56.6% | $494.7M-3.5% | $494.5M+45.0% | $484.2M+49.3% | $460.5M+45.7% | $512.6M+112.3% |
| Inventory | $299.0M+55.8% | $336.7M+83.6% | $196.6M+7.5% | $191.0M0.0% | $191.9M-1.4% | $183.4M-7.5% | $182.9M-1.9% | $191.1M-0.6% |
| Long-Term Investments | $34.9M-8.4% | $26.2M-18.2% | $145K-99.8% | $27.7M+47.7% | $38.1M-55.8% | $32.0M-47.4% | $73.0M+91.8% | $18.8M-82.1% |
| Goodwill | $594.3M | $596.0M | $83.0M0.0% | N/A | N/A | N/A | $83.0M0.0% | $83.0M-10.6% |
| Total Liabilities | $2.6B+311.4% | $2.5B+339.4% | $667.7M+13.1% | $596.1M-30.9% | $628.2M-31.9% | $570.4M-34.4% | $590.6M-36.7% | $863.2M-6.5% |
| Current Liabilities | $662.1M+30.9% | $599.5M+35.1% | $543.4M+16.8% | $474.4M+4.6% | $506.0M-1.9% | $443.7M-3.3% | $465.2M-10.6% | $453.7M-9.8% |
| Non-Current Liabilities | $1.9B+1472.4% | $1.9B+1405.6% | $124.3M-0.9% | $121.7M-70.3% | $122.3M-70.0% | $126.7M-69.1% | $125.4M-69.7% | $409.5M-2.6% |
| Long-Term Debt | $1.5B | $1.5B | $0 | N/A | N/A | N/A | N/A | $285.8M-0.9% |
| Total Equity | $1.8B+11.3% | $1.8B+15.9% | $1.8B+24.2% | $1.7B+34.2% | $1.6B+26.5% | $1.5B+20.5% | $1.5B+21.8% | $1.3B-4.7% |
| Retained Earnings | -$800.8M+7.6% | -$801.3M+16.0% | -$734.8M+24.7% | -$784.1M+30.2% | -$866.9M+28.7% | -$954.0M+27.0% | -$976.5M+27.3% | -$1.1B+22.9% |
Not reported in any period shown, so not listed: Accounts Receivable.
ALKS Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $145.2M-3.3% | -$165.7M-267.7% | $170.1M-10.7% | $101.7M+24.6% | $150.2M+2.9% | $98.8M+368.1% | $190.4M+77.5% | $81.6M-18.2% |
| Depreciation & Amortization | $30.3M+287.3% | $19.4M+161.8% | $3.8M-43.8% | $8.1M+15.9% | $7.8M+17.4% | $7.4M-7.9% | $6.8M-63.1% | $7.0M-62.6% |
| Stock-Based Compensation | $31.1M+24.7% | $36.3M+59.3% | N/A | N/A | $25.0M+21.2% | $22.8M-30.4% | N/A | $22.5M-5.8% |
| Capital Expenditures | $8.1M-37.4% | $4.1M-59.5% | -$20K-99.8% | $17.3M+109.7% | $13.0M+83.0% | $10.1M+21.2% | $9.8M-42.6% | $8.3M-42.9% |
| Free Cash Flow | $137.0M-0.1% | -$169.8M-291.5% | $170.0M-5.9% | $84.4M+15.0% | $137.2M-1.2% | $88.7M+594.8% | $180.6M+100.2% | $73.3M-14.0% |
| Investing Cash Flow | -$2.4M+91.7% | -$2.1B-22919.2% | $322.3M+2423.2% | -$6.7M+93.8% | -$29.2M-156.3% | $9.1M+122.8% | -$13.9M+33.9% | -$109.3M+8.4% |
| Financing Cash Flow | $17.2M+4148.1% | $1.5B+197292.1% | $10.9M+103.9% | $315K+100.3% | $405K+100.5% | $747K+104.2% | -$281.7M-1.9% | -$111.1M-7190.9% |
| Share Buybacks | $0 | $27.7M | N/A | N/A | N/A | N/A | $1K | $115.6M |
Not reported in any period shown, so not listed: Dividends Paid.
ALKS Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 80.2%-7.1pp | 84.3%+0.4pp | 88.0%+2.4pp | 86.9%+3.6pp | 87.3%+2.7pp | 84.0%+0.7pp | 85.5%+4.1pp | 83.3%-0.6pp |
| Operating Margin | 3.7%-20.1pp | -12.3%-16.8pp | 15.1%-22.7pp | 22.6%-5.1pp | 23.8%-3.7pp | 4.5%-7.9pp | 37.8%+23.4pp | 27.7%+4.3pp |
| Net Margin | 0.1%-22.2pp | -16.9%-24.3pp | 12.8%-21.2pp | 21.0%-3.4pp | 22.3%-0.6pp | 7.3%-3.2pp | 34.1%+4.2pp | 24.4%+11.9pp |
| Return on Equity | 0.0%-5.3pp | -3.8%-5.3pp | 2.7%-7.3pp | 4.8%-2.4pp | 5.4%-1.8pp | 1.5%-1.4pp | 10.0%+0.6pp | 7.1%+3.6pp |
| Return on Assets | 0.0%-3.9pp | -1.6%-2.6pp | 2.0%-5.1pp | 3.5%-0.7pp | 3.9%-0.3pp | 1.1%-0.6pp | 7.1%+1.9pp | 4.3%+2.2pp |
| Current Ratio | 2.30-0.9x | 2.27-1.1x | 3.55+0.5x | 3.67+0.2x | 3.23+0.2x | 3.33+0.1x | 3.04+0.2x | 3.45+0.5x |
| Debt-to-Equity | 0.82+0.4x | 0.85+0.5x | 0.00-0.4x | 0.34+0.1x | 0.39+0.2x | 0.38+0.1x | 0.40+0.2x | 0.220.0x |
| Asset Turnover | 0.11-0.1x | 0.09-0.1x | 0.15-0.1x | 0.170.0x | 0.170.0x | 0.150.0x | 0.210.0x | 0.180.0x |
| FCF Margin | 27.6%-7.5pp | -43.2%-72.2pp | 44.2%+2.2pp | 21.4%+2.0pp | 35.1%+0.3pp | 28.9%+25.3pp | 42.0%+18.1pp | 19.4%-3.0pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Alkermes Inc. plc ALKS | FY2025 | $1.5B | $241.7M | 16.4% | $7.2B | 73/100 |
| Lantheus Holdings, Inc LNTH | FY2025 | $1.5B | $233.6M | 15.2% | $6.5B | 71/100 |
| Indivior Pharmaceuticals, Inc. INDV | FY2025 | $1.2B | $210.0M | 17.0% | $3.8B | 44/100 |
| Amneal Pharmaceuticals, Inc. AMRX | FY2025 | $3.0B | $72.1M | 2.4% | $6.7B | 56/100 |
| HUTCHMED (China) Limited HCM | FY2025 | $548.5M | $456.9M | 83.3% | $2.4B | 42/100 |
| Prestige Consumer Healthcare Inc. PBH | FY2026 | $1.1B | $190.3M | 17.5% | $2.4B | 61/100 |
Where Alkermes Inc. plc Ranks
Frequently Asked Questions
What is Alkermes Inc. plc's annual revenue?
Alkermes Inc. plc (ALKS) reported $1.5B in total revenue for fiscal year 2025. This represents a -5.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Alkermes Inc. plc's revenue growing?
Alkermes Inc. plc (ALKS) revenue declined by 5.2% year-over-year, from $1.6B to $1.5B in fiscal year 2025.
Is Alkermes Inc. plc profitable?
Yes, Alkermes Inc. plc (ALKS) reported a net income of $241.7M in fiscal year 2025, with a net profit margin of 16.4%.
What is Alkermes Inc. plc's EBITDA?
Alkermes Inc. plc (ALKS) had EBITDA of $281.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Alkermes Inc. plc have?
As of fiscal year 2025, Alkermes Inc. plc (ALKS) had $388.6M in cash and equivalents against $0 in long-term debt.
What is Alkermes Inc. plc's gross margin?
Alkermes Inc. plc (ALKS) had a gross margin of 86.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Alkermes Inc. plc's operating margin?
Alkermes Inc. plc (ALKS) had an operating margin of 17.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Alkermes Inc. plc's net profit margin?
Alkermes Inc. plc (ALKS) had a net profit margin of 16.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Alkermes Inc. plc's return on equity (ROE)?
Alkermes Inc. plc (ALKS) has a return on equity of 13.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Alkermes Inc. plc's free cash flow?
Alkermes Inc. plc (ALKS) generated $480.3M in free cash flow during fiscal year 2025. This represents a 18.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Alkermes Inc. plc's operating cash flow?
Alkermes Inc. plc (ALKS) generated $520.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Alkermes Inc. plc's total assets?
Alkermes Inc. plc (ALKS) had $2.5B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Alkermes Inc. plc's capital expenditures?
Alkermes Inc. plc (ALKS) invested $40.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Alkermes Inc. plc spend on research and development?
Alkermes Inc. plc (ALKS) invested $324.0M in research and development during fiscal year 2025.
What is Alkermes Inc. plc's current ratio?
Alkermes Inc. plc (ALKS) had a current ratio of 3.55 as of fiscal year 2025, which is generally considered healthy.
What is Alkermes Inc. plc's debt-to-equity ratio?
Alkermes Inc. plc (ALKS) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Alkermes Inc. plc's return on assets (ROA)?
Alkermes Inc. plc (ALKS) had a return on assets of 9.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Alkermes Inc. plc's P/E ratio?
Alkermes Inc. plc (ALKS) trades at 109x earnings, its market capitalization divided by net income of $66.2M net income, trailing 12 months to June 30, 2026. The market capitalization is $7.2B as of Oct 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Alkermes Inc. plc's price-to-sales ratio?
Alkermes Inc. plc (ALKS) trades at 4.3x sales, its market capitalization divided by revenue of $1.7B revenue, trailing 12 months to June 30, 2026. The market capitalization is $7.2B as of Oct 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Alkermes Inc. plc's Altman Z-Score?
Alkermes Inc. plc (ALKS) has an Altman Z-Score of 7.66, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Alkermes Inc. plc's Piotroski F-Score?
Alkermes Inc. plc (ALKS) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Alkermes Inc. plc's earnings high quality?
Alkermes Inc. plc (ALKS) has an earnings quality ratio of 2.15x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Alkermes Inc. plc cover its interest payments?
Alkermes Inc. plc (ALKS) has an interest coverage ratio of 20.69x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Alkermes Inc. plc?
Alkermes Inc. plc (ALKS) scores 73 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.